Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Sepsis Scout
AddedFeb 17, 2024
UpdatedJul 3, 2026
Sepsis Scout

Sepsis Scout

Acquired

AI wearables for at-home sepsis prevention.

HQ
San Francisco, CA, US
Founded
2017
Accelerator
Y Combinator logoY CombinatorW18
Overview
Compare
Fundraising
Employees

Sepsis Scout, formerly known as Patchd Medical, was founded with the mission to predict and prevent sepsis outside of hospital settings, particularly among cancer patients. The company leverages wearable technology combined with proprietary deep learning algorithms to detect early signs of sepsis, aiming to intervene before the condition becomes critical. Sepsis Scout focuses on providing at-home monitoring solutions to improve patient outcomes and reduce sepsis-related mortality.

Notable figures associated with Sepsis Scout include its founding team of healthcare and technology experts. The company has garnered attention and support from investors interested in healthcare innovation and AI applications. Key achievements include the successful integration of AI with off-the-shelf wearables, demonstrating significant potential in early sepsis detection. Sepsis Scout's impact lies in its ability to offer a proactive approach to sepsis management, potentially saving thousands of lives by enabling timely medical intervention.

Sepsis Scout - Similar Companies

Zeit Medical logo

Zeit Medical

zeitmedical.com

Starling logo

Starling

Impact Vitals logo

Impact Vitals

impactvitals.com

Senseer Health logo

Senseer Health

senseer.us

Stat Health logo

Stat Health

stat-health.com

Vena Vitals logo

Vena Vitals

venavitals.com

Scanbase logo

Scanbase

scanbase.com

BioscanR logo

BioscanR

iSono Health logo

iSono Health

isonohealth.com

Respira Labs logo

Respira Labs

Clinicai logo

Clinicai

Zealth logo

Zealth

zealth-ai.com

Sanus Solutions logo

Sanus Solutions

sanussolutions.com

Unstatiq logo

Unstatiq

unstatiq.com

BioticsAI logo

BioticsAI

biotics.ai

Sepsis Scout - Quick Facts

Who are Sepsis Scout's competitors?

Companies similar to Sepsis Scout include Zeit Medical, Starling, Impact Vitals and Senseer Health.

When was Sepsis Scout founded?

Sepsis Scout was founded in 2017.

Where is Sepsis Scout's headquarters located?

Sepsis Scout's headquarters is located in San Francisco, CA, US.

When was Sepsis Scout's last funding round?

Sepsis Scout's most recent funding round was for $1M (USD) in June 2019.

How much has Sepsis Scout raised to-date?

As of Jun 17, 2019, Sepsis Scout has raised a total of $2.9M (USD).

Sepsis Scout - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • HealthTech
Revenue
  • Recurring
Main Product
  • AI
  • Wearables
Tags
  • SaaS
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software
Show 10 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7371Computer Programming Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified